N-hydroxy bicyclic hydantoin carbamates as tools for identification of serine hydrolase targets
US9981972B2 · kind B2 · utility
0Cited by
4References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 20, 2015 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | May 20, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/34
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are N-hydroxy bicyclic hydantoin carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of serine hydrolases. Furthermore, the subject compounds and compositions are useful for the treatment of one or more of cancer, pain, diabetes, obesity/metabolic syndrome, epilepsy, traumatic brain injury, and inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.